Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380042 · ClinicalTrials.gov registry record · Phase 1
Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder
A Phase 1 study, sponsored by Northstar Neuroscience.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT00380042 is a Phase 1 study that was terminated before completion, run by Northstar Neuroscience. The registered enrollment target is 12 participants.
The verdict
NCT00380042, a Phase 1 study, was terminated before completion, sponsored by Northstar Neuroscience.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and effectiveness of cortical stimulation to the cerebral cortex of subjects who have suffered from treatment-resistant depression and have failed routine attempts at controlling their depression.
Interventions
- DEVICE Sham
- DEVICE Cortical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00380042
The ClinicalTrials.gov registry entry for NCT00380042 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northstar Neuroscience, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT00380042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00380042 about?
NCT00380042 is a clinical study titled "Assessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive Disorder". The purpose of this study is to assess the safety and effectiveness of cortical stimulation to the cerebral cortex of subjects who have suffered from treatment-resistant depression and have failed routine attempts at controlling their depression.
What is the current status of trial NCT00380042?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2006-09. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00380042?
The interventions under investigation include: Sham (DEVICE), Cortical Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00380042?
This trial is sponsored by Northstar Neuroscience, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.